阻塞性睡眠呼吸暂停低通气综合征与甲状腺功能减退症的关系

doi:10.3969/j.issn.1004-583X.2016.03.028

摘要/Abstract

摘要： 随着睡眠医学的发展以及诊断技术的完善普及,越来越多的人被诊断出患有阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea-hypopnea syndrome, OSAHS)。肥胖是OSAHS发病的独立危险因素,随着超重及肥胖人群的增长,OSAHS的患病率势必会相应增加。大量证据显示OSAHS不仅可增加心脑血管事件风险,且与内分泌激素水平、糖尿病、代谢综合征、骨质疏松症等密切相关。OSAHS和甲状腺功能减退症(简称甲减)都是临床上的常见病及多发病,两者的临床表现可出现部分重叠,如淡漠、精神差、注意力不集中、疲倦、嗜睡、乏力等,所以临床上可能出现诊断其中某一种疾病后,忽略另外一种疾病的存在。本文结合OSAHS与甲减的相关研究,对OSAHS与甲减的相互作用关系进行初步探讨。

关键词: 睡眠呼吸暂停, 阻塞性, 甲状腺功能减退症, 肥胖

中图分类号:

R581

都建苹,安振梅. 阻塞性睡眠呼吸暂停低通气综合征与甲状腺功能减退症的关系[J]. 临床荟萃, 2016, 31(3): 342-344.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.03.028

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I3/342

参考文献

[1] 张庆, 何权瀛, 杜秋艳, 等. 承德市区居民睡眠呼吸暂停低通气综合征患病率入户调查[J]. 中华结核和呼吸杂志,2003,26(5): 273-275.
[2] Ip MS, Lam B, Lauder IJ, et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong[J]. Chest,2001,119(1): 62-69.
[3] 李敏, 李庆云, 倪瑾华, 等. 上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J]. 中华结核和呼吸杂志,2003,26(5): 268-272.
[4] 王蓓, 邢景才, 韩长旭, 等. 太原市睡眠呼吸暂停低通气综合征的流行病学调查[J]. 中华结核和呼吸杂志, 2004,27(11): 760-762.
[5] 李明娴, 王莹, 华树成, 等. 长春市20岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学现况调查[J]. 中华结核和呼吸杂志,2005,28(12): 833-835.
[6] 何权瀛, 陈宝元. 睡眠呼吸病学[M]. 北京:人民卫生出版社, 2009:93-145.
[7] Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults[J]. J Clin Sleep Med,2009,5(3): 263-276.
[8] 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J]. 中华结核和呼吸杂志, 2012,35(1): 9-12.
[9] Veasey SC, Guilleminault C, Strohl KP, et al. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine[J]. Sleep, 2006,29(8): 1036-1044.
[10] 余叶蓉. 内分泌与代谢疾病[M]. 北京:人民卫生出版社,2012:127.
[11] Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea[J]. J Clin Endocrinol Metab,2010, 95(2): 483-495.
[12] Fukusumi M, Iidaka T, Mouri A, et al. Respiratory failure associated with hypoventilation in a patient with severe hypothyroidism[J]. Respirol Case Rep, 2014,2(2): 79-80.
[13] Jha A, Sharma SK, Tandon N, et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism[J]. Sleep Med, 2006,7(1): 55-61.
[14] Bahammam SA, Sharif MM, Jammah AA, et al. Prevalence of thyroid disease in patients with obstructive sleep apnea[J]. Respir Med, 2011,105(11): 1755-1760.
[15] Miller CM, Husain AM. Should women with obstructive sleep apnea syndrome be screened for hypothyroidism?[J].Sleep Breath, 2003,7(4): 185-188.
[16] Takeuchi S, Kitamura T, Ohbuchi T, et al. Relationship between sleep apnea and thyroid function[J]. Sleep Breath, 2015,19(1): 85-89.
[17] Lanfranco F. Sleep apnea syndrome and hypothyroidism[J]. Endocrine, 2013,44(3): 551-552.
[18] Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism[J]. Chest, 1992,102(6): 1663-1667.
[19] Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea[J]. Am J Respir Crit Care Med,1999,160(2): 732-735.
[20] Mickelson SA, Lian T, Rosenthal L. Thyroid testing and thyroid hormone replacement in patients with sleep disordered breathing[J]. Ear Nose Throat J,1999,78(10): 768-771, 774-775.
[21] Misiolek M, Marek B, Namyslowski G, et al. Sleep apnea syndrome and snoring in patients with hypothyroidism with relation to overweight[J]. J Physiol Pharmacol, 2007, 58 (Suppl 1): 77-85.
[22] Winkelman JW, Goldman H, Piscatelli N, et al. Are thyroid function tests necessary in patients with suspected sleep apnea [J]. Sleep,1996,19(10): 790-793.
[23] Kapur VK, Koepsell TD, de Maine J, et al. Association of hypothyroidism and obstructive sleep apnea[J]. Am J Respir Crit Care Med,1998,158(5 Pt 1): 1379-1383.
[24] Sakellaropoulou AV, Hatzistilianou MN, Emporiadou MN, et al. Evaluation of thyroid gland function in children with obstructive apnea hypopnea syndrome[J]. Int J Immunopathol Pharmacol, 2011,24(2): 377-386.
[25] Resta O, Pannacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing[J]. Nutr Metab Cardiovasc Dis, 2004,14(5): 248-253.
[26] Bottini P, Tantucci C.Sleep apnea syndrome in endocrine diseases[J].Respiration,2003,70(3): 320-327.
[27] 李義, 张劭夫. 实用呼吸病学[M]. 北京:化学工业出版社, 2010:458.
[28] Barcelo A, Miralles C, Barbe F, et al. Abnormal lipid peroxidation in patients with sleep apnoea[J]. Eur Respir J, 2000,16(4): 644-647.
[29] Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy[J]. Am J Respir Crit Care Med, 2000,162(2 Pt 1): 566-570.
[30] Christou K, Kostikas K, Pastaka C, et al. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome[J]. Sleep Med,2009, 10(1): 87-94.
[31] Katsoulis K, Kontakiotis T, Spanogiannis D, et al. Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease[J]. Sleep Breath, 2011,15(4): 861-866.
[32] Eisele HJ, Markart P, Schulz R. Obstructive sleep apnea,oxidative stress, and cardiovascular disease: evidence from human studies[J]. Oxid Med Cell Longev, 2015,2015: 608438.Epub 2015 Jun 8.
[33] Lanfranco F, Motta G, Minetto MA, et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome[J]. Int J Endocrinol, 2010,2010: 474518.
[34] Meston N, Davies RJ, Mullins R, et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea[J]. J Intern Med, 2003,254(5): 447-454.
[35] Bratel T, Wennlund A, Carlstrm K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP) [J]. Respir Med,1999, 93(1): 1-7.
[36] Bozkurt NC, Karbek B, Cakal E, et al. The association between severity of obstructive sleep apnea and prevalence of Hashimoto's thyroiditis[J]. Endocr J, 2012, 59(11): 981-988.
[37] Lanfranco F, Gianotti L, Pivetti S, et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function[J]. Clin Endocrinol (Oxf), 2004, 60(1): 41-48.